As per the latest report by Renub Research titled "Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients' tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient's cancer that best matches, or targets, the culprit mutations in the tumor DNA.

Likewise, some of the more common cancers where precision medicine is being used to help with treatment decisions include Lung Cancer, Stomach Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Colorectal Cancer, Breast Cancer, r, cervical cancer, Kidney Cancer, and Bladder Cancer. Notwithstanding, the existing oncology precision medicine market is preferred by multiple factors, including several government initiatives, rising cancer incidences, and death rates, coupled with the general population's growing awareness about molecular-level diagnosis and treatment. Besides, the increasing number of advancements in molecular diagnostics, increasing FDA approvals for such precision medicine-based oncology drugs, enhancing focus on research and development activities by crucial healthcare companies also led to market expansion. Furthermore, the development of newer therapeutic approaches, including gene therapy for cancer treatment and a rising number of patients undergoing predictive diagnosis, will propel the market growth.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=oncology-precision-medicine-market-p.php

COVID-19 Impact on Oncology Precision Market

COVID-19 has impacted the oncology precision medicine market. This impact was mainly due to disturbance of the supply chain and lockdowns imposed in many countries. Nevertheless, as the lockdowns were raised and supply was restored, the market has recovered quickly. As precision medicine deals majorly with fatal disorders like cancer involving life-saving drugs, the COVID-19 pandemic is poised to impact the market during the assessment period. Majorly for individuals living with cancer, the pandemic posed a unique set of challenges. The pandemic has certainly hindered surgeries and testing on biopsy tissue and has also impacted cancer patients' ability to receive provider-administered drugs. Thus, the volume of oncology precision drugs and services declined notably in 2020.

Hospital end-users accounted for the largest share of the global oncology precision medicine market

On the basis of end-user, the global oncology precision medicine market is categorized into Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others. The hospital's segment accounted for the most significant market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of cancer diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine. As per our research findings, Worldwide oncology precision medicine market was USD 33.40 Billion in 2021

North Americans raise oncology precision medicine production:

Geographically, North America is leading the oncology precision medicine market. The number of cancer patients in North America is growing notably. According to the (ACS) American Cancer Society, cancer is the leading reason of death in Canada and the second leading cause of death in the U.S. In U.S, about 1.8 million new cancer cases were diagnosed in 2020. High awareness in the region regarding precision medicine and increasing demand for personalized cancer treatment will drive the industry revenue in the region. The level of medical procedures, such as radiation, chemotherapy, and immunotherapy required, will depend upon the stage and type of cancer. Precision medicines play an essential role in helping physicians determine a suitable treatment plan based on the current genetic mutations of the patient.

Similarly, oncology precision medicine treatments have gained momentum among clients in the Asia-Pacific region in the past few years. They utilize advanced technologies and innovative methods to create personalized medicines that cater to patients' medical needs. The global precision medicine market players are Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/oncology-precision-medicine-market-p.php

Market Summary:

• Product Type – We have covered Global Oncology Precision Medicine Market breakup by 2 viewpoints by- product type (Diagnostics and Therapeutics)
• Indication – Renub Research Report covers by Indication in the 11 viewpoints (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer)
• End Users – Our Report has covered Global Oncology Precision Medicine Market breakup by 4 End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others)
• Region - This Report covers by Region in the 5 viewpoints (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

Rising Dialysis Cases in the North American Region will Fuel the Industry's Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

Market Summary:

• Type - We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
• Product & Services - Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
• End-Users - Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
• Regions - Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Bioplastic Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Bioplastic Market Size was USD 6.7 Billion in 2021. Bioplastic is recognized as a very positive and essential innovation in the plastics and chemicals industry. Bioplastic is materials emanated from renewable sources that can reduce plastic waste generation on the planet. It can reduce 30-70% of carbon dioxide emissions. It represents an approximately 42% reduction of carbon footprints. The production of bioplastic requires 65% less energy than conventional petroleum plastic. These bio-based plastics are generally sourced from renewable biomass sources, including vegetable fats, natural sugars, cellulose, plant starch, and waste oils.

Over the short term, significant factors driving the market studied are environmental factors promoting a paradigm shift and increasing demand for bioplastics in flexible packaging. The ecological dilemma caused by reaching high levels of greenhouse gas emissions in the atmosphere is one of the main drivers for the bioplastic industry, as bioplastic help to reduce the dependency on fossil resources, reduce greenhouse gas (GHG) emissions, and increase resource efficiency.

COVID-19 Impact on Bioplastics Growth Trends

The bioplastic market was positively impacted by COVID-19. Amid the lockdown situation, the demand for flexible packaging has increased, owing to the rise in demand for food, pharma, and PPE packaging personal and healthcare products. However, sustainable plastics can be an excellent alternative to conventional plastics, thus delivering an alternative growth pathway to the bioplastic industry in the wake of the COVID -19 pandemic.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=bioplastics-market-p.php

Non-biodegradable Plastics Polyethylene Terephthalate (PET) Segment led the Market

Non-biodegradable bioplastic are further categorized into Polyethylene (P.E.), Polyethylene terephthalate (PET), Polyamide (P.A.), Polypropylene (P.P.), Poly(trimethylene terephthalate) (PTT) and Others. Polyethylene terephthalate is an ideal choice for use in various industries such as automotive, electronics, and textiles due to its features. Polyethylene terephthalate, commonly known as PET, is a lightweight, non-toxic, safe, and flexible material that can be reused and recycled efficiently. It can also be processed 3 to 4 times without impacting its chemical properties. Meanwhile, polyethylene terephthalate offers unique physical properties, such as it is shatterproof and non-reactive to food and water, so it is widely utilized in flexible packaging applications. The growing technological advances and innovations in packaging applications, mainly through weight reduction, will positively influence market growth.

Packaging Application is anticipated to Exhibit Rapid Growth

The adoption of bioplastic has increased tremendously across various applications like packaging, agriculture, consumer goods, textile, automotive and transportation, and building and construction, owing to the advanced technical properties and functionalities. Bio-based plastics have found traction in packaging applications due to shipping companies seeking sustainable sturdy packaging products. The packaging segment is further divided into jars, trays, bottles & and others, while flexible packaging is further categorized into shopping/waste, pouches, bags, etc. Moreover, most packaging products are nowadays produced from traditional plastics and end up in landfills, which is a situation that various governments intend to address.

Regionally, North America accounted for the Largest Bioplastics Market

North America's bioplastics market is majorly caused by the growing demand from the packaging industry in countries like Canada, U.S., and Mexico. Rising environmental concerns and a global attempt to decrease pollution are propelling the demand for biodegradable plastics in the packaging sector across the region. In addition, increasing COVID-19 cases in the U.S. results in a raised demand for generic drugs and medical devices, this boosts the demand for bioplastics in the medical packaging sector, positively impacting the market growth.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/bioplastics-market-p.php

Similarly, Asia Pacific is likely to have a considerable market due to the availability of skilled labor at a low cost. Further, easy land availability for manufacturing industries drives the regional market. The transformation in the production landscape of biodegradable plastics toward emerging economies, particularly China and India, is to influence bioplastics market growth positively. The bioplastics market is fragmented into key players like Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

Market Summary:

Material Type - We have covered Bioplastics Market breakup by 2 viewpoints by- Material Type (Biodegradable (Polybutylene adipate Terephthalate (PBAT),Polybutylene Succinate (PBS),Polylactic Acid (PLA),Polyhydroxyalkanoate (PHA),Starch Blends and Others), Non Biodegradable (Polyethylene (PE),Polyethylene terephthalate (PET),Polyamide (PA), Polypropylene (PP,Polytrimethylene terephthalate) ( PTT) and Others))

Application - Renub Research Report covers by application in the 6 viewpoints (Packaging, Agriculture, Consumer Goods, Textile, Automotive and Transportation, And Building and Construction)

Region – Our Report has covered Bioplastics Market breakup by 4 Region (North America, Europe, Asia Pacific and Rest of the Word)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch